Registry for Ehlers-Danlos Syndrome
Official title: Registry of Ehlers-Danlos Syndrome That Collects Clinical, Functional, Genetic, Genealogical, Imaging, Surgical, Treatment, Quality of Life Data. Data Are Linked to Patients' Biological Samples, When Available
Run by Istituto Ortopedico Rizzoli · NCT04133272 · Data updated 2026-11-12
This study is creating a registry to gather information from people with Ehlers-Danlos Syndrome to help researchers learn more about the condition and improve care for patients.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Istituto Ortopedico Rizzoli Academic / other |
| Locations | 1 site (Bologna, Emilia-Romagna) |
| Status | Recruiting |
| Started | June 2014 |
| Main results expected | June 2027 |
| Study ends | January 2033 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT04133272 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals diagnosed with Ehlers-Danlos Syndrome, including those with prenatal and fetal diagnoses.
✕Probably not a fit
Patients with conditions unrelated to Ehlers-Danlos Syndrome will not benefit from participation in this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects and integrates data from patients with Ehlers-Danlos Syndrome to better understand the disease's natural history and genetic correlations. It utilizes a web-accessible platform called GeDI, which complies with GDPR and is designed to streamline data collection and analysis. The registry includes various data domains such as personal information, clinical data, genetic data, and family history to facilitate comprehensive research and improve patient care.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of Ehlers-Danlos Syndrome, leading to improved diagnosis and treatment options for patients.
How similar studies have gone: Other studies utilizing disease registries for rare conditions have shown success in improving patient outcomes and advancing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All Ehlers-Danlos Syndrome patients, including prenatal and fetal diagnosis of Ehlers-Danlos Syndrome Exclusion Criteria: * Any condition unrelated to Ehlers-Danlos Syndrome
Where it's running
-
Irccs Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy Recruiting
Study contacts
- Principal investigator: Luca Sangiorgi, MD, PhD, MS — Istituto Ortopedico Rizzoli
- Study coordinator: Marina Mordenti, PhD
- Email: registri.malattierare@ior.it
- Phone: +39 05 6366062
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
-
Repair of complex aortic aneurysms using custom devices
This study is testing custom-made devices to see if they can safely and effectively treat complex aortic aneurysms in patients who can't use standard options, especially those at high risk or with conditions like Marfan syndrome.
-
Archive of Custom-Made Guides for Orthopedic Surgery
Researchers are testing a digital archive to store and track patient-specific cutting guides used in orthopedic surgeries for people with bone deformities.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
ACL reconstruction using the Over-The-Top technique with either metal staples or soft anchors
This study tests whether using a suture-based fixation (soft anchors) during OTT ACL reconstruction works as well as metal staples for graft stability in adults aged 18–50.
-
Biomarkers in circulating vesicles for Ewing sarcoma
Researchers will test blood samples from people with Ewing sarcoma to see if circulating biomarkers in extracellular vesicles can help validate new therapies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.